Physiomics PLC Director/PDMR Shareholding (9416S)
22 Marzo 2021 - 1:00AM
UK Regulatory
TIDMPYC
RNS Number : 9416S
Physiomics PLC
22 March 2021
22 March 2021
Physiomics plc
("Physiomics") or ("the Company")
Director Dealing
The Company announces that Dr Jim Millen, Chief Executive
Officer of Physiomics, has been notified that a brokerage account
with Reyker Securities plc ("Reyker") in which he held an interest
of 244,641 ordinary shares of 0.4p each in the Company ("Ordinary
Shares"), has been closed and transferred to a brokerage account
with James Brearley & Sons Limited, for no consideration (the
"Transfer"). The Transfer occurred as a result of Reyker entering
special administration on 9 October 2019 and the Ordinary Shares
subject to the Transfer remain beneficially owned by Dr Millen.
Further, Dr Millen understands that 2,354 Ordinary Shares were sold
during the administration process to cover certain account charges,
although Dr Millen has not been notified of the timing and price of
this sale.
Accordingly, Dr Millen's holding in the Company is 1,384,393
Ordinary Shares, representing approximately 1.42 per cent. of the
Company's issued share capital.
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
Hybridan LLP (broker)
Claire Louise Noyce
+44 (0) 203 764 2341
Strand Hanson Ltd (NOMAD)
James Dance & James Bellman
+44 (0)20 7409 3494
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name James Millen
------------------------------------------------------------ -----------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------------------------------------
a) Position/status Director, CEO
------------------------------------------------------------ -----------------------------------------
b) Initial notification/ Amendment Initial notification
------------------------------------------------------------ -----------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
-------------------------------------------------------------------------------------------------------
a) Name Physiomics plc
------------------------------------------------------------ -----------------------------------------
b) LEI 213800A71DSZ6ABMTQ91
------------------------------------------------------------ -----------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
-------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary share
Identification code
GB00BDR6W943
------------------------------------------------------------ -----------------------------------------
b) Nature of the transaction Disposal and transfer of Ordinary Shares
------------------------------------------------------------ -----------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Unknown 2,354
----------
N/A 242,287
----------
------------------------------------------------------------ -----------------------------------------
d) Aggregated information
* Aggregated volume 244,641
Unknown / N/A
* Price
------------------------------------------------------------ -----------------------------------------
e) Date of the transaction Transfer occurred on 29 January 2021
------------------------------------------------------------ -----------------------------------------
f) Place of the transaction XLON, AIM
------------------------------------------------------------ -----------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHJBMFTMTBTBFB
(END) Dow Jones Newswires
March 22, 2021 03:00 ET (07:00 GMT)
Physiomics (LSE:PYC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Physiomics (LSE:PYC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
